About this journal
Aims and scope
Therapeutics and Clinical Risk Management is an international, peer-reviewed journal of clinical therapeutics and risk management, focusing on concise rapid reporting of clinical studies in all therapeutic areas, outcomes, safety, and programs for the effective, safe, and sustained use of medicines, therapeutic and surgical interventions in all clinical areas.
The journal welcomes submissions covering original research, clinical and epidemiological studies, reviews, guidelines, expert opinion and commentary.
The journal does not accept study protocols, animal-based or cell line-based studies.
Case reports/series submitted to Therapeutics and Clinical Risk Management will be diverted to the International Medical Case Reports Journal (Journal metric data for this journal can be accessed here).
When considering submission of a paper utilizing publicly-available data (e.g. SEER), authors should ensure that such studies add significantly to the body of knowledge about a specific disease or relevant phenotype and that they are validated using the authors own data through replication in an original sample and functional follow-up.
All meta-analyses require a pre-submission check prior to submitting to Therapeutics and Clinical Risk Management. Please complete the pre-submission check form here.
Journal metrics
Usage
- 255K annual downloads/views
Citation metrics
- 2.3 (2023) Impact Factor
- Q2 Impact Factor Best Quartile
- 2.3 (2023) 5 year IF
- 5.3 (2023) CiteScore (Scopus)
- Q1 CiteScore Best Quartile
- 0.963 (2023) SNIP
- 0.752 (2023) SJR
Understanding and using journal metrics
Journal metrics can be a useful tool for readers, as well as for authors who are deciding where to submit their next manuscript for publication. However, any one metric only tells a part of the story of a journal’s quality and impact. Each metric has its limitations which means that it should never be considered in isolation, and metrics should be used to support and not replace qualitative review.
We strongly recommend that you always use a number of metrics, alongside other qualitative factors such as a journal’s aims & scope, its readership, and a review of past content published in the journal. In addition, a single article should always be assessed on its own merits and never based on the metrics of the journal it was published in.
For more details, please read the Author Services guide to understanding journal metrics.
Journal metrics in brief
Usage and acceptance rate data above are for the last full calendar year and are updated annually in February. Speed data is updated every six months, based on the prior six months. Citation metrics are updated annually mid-year. Please note that some journals do not display all of the following metrics (find out why).
- Usage: the total number of times articles in the journal were viewed by users of Taylor & Francis Online in the previous calendar year, rounded to the nearest thousand.
Citation Metrics
- Impact Factor*: the average number of citations received by articles published in the journal within a two-year window. Only journals in the Clarivate Science Citation Index Expanded (SCIE), Social Sciences Citation Index (SSCI), Arts and Humanities Citation Index (AHCI) and the Emerging Sources Citation Index (ESCI) have an Impact Factor.
- Impact Factor Best Quartile*: the journal’s highest subject category ranking in the Journal Citation Reports. Q1 = 25% of journals with the highest Impact Factors.
- 5 Year Impact Factor*: the average number of citations received by articles in the journal within a five-year window.
- CiteScore (Scopus)†: the average number of citations received by articles in the journal over a four-year period.
- CiteScore Best Quartile†: the journal’s highest CiteScore ranking in a Scopus subject category. Q1 = 25% of journals with the highest CiteScores.
- SNIP (Source Normalized Impact per Paper): the number of citations per paper in the journal, divided by citation potential in the field.
- SJR (Scimago Journal Rank): Average number of (weighted) citations in one year, divided by the number of articles published in the journal in the previous three years.
Speed/acceptance
- From submission to first decision: the average (median) number of days for a manuscript submitted to the journal to receive a first decision. Based on manuscripts receiving a first decision in the last six months.
- From submission to first post-review decision: the average (median) number of days for a manuscript submitted to the journal to receive a first decision if it is sent out for peer review. Based on manuscripts receiving a post-review first decision in the last six months.
- From acceptance to online publication: the average (median) number of days from acceptance of a manuscript to online publication of the Version of Record. Based on articles published in the last six months.
- Acceptance rate: articles accepted for publication by the journal in the previous calendar year as percentage of all papers receiving a final decision.
For more details on the data above, please read the Author Services guide to understanding journal metrics.
*Copyright: Journal Citation Reports®, Clarivate Analytics
†Copyright: CiteScore™, Scopus
Editorial board
Editor-in-Chief:
Professor Garry Walsh, School of Medicine, University of Aberdeen, United Kingdom
Associate Editor-in-Chief:
Professor Deyun Wang, Department of Otolaryngology, University of Singapore, Singapore
Editorial Board:
Professor Shahin Akhondzadeh, Clinical Psychopharmacology, Tehran University of Medical Sciences, Iran
Professor Guang-Yan Cai, Department of Nephrology, State Key Laboratory of Kidney Diseases, Chinese PLA General Hospital, China Mainland (PRC)
Dr Zhuang-Gui Chen, Pediatrics, the Third Affiliated Hospital of Sun Yat-Sen University, China Mainland (PRC)
Dr William Cho, Department of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong, People's Republic of China.
Mr Mark Duman, Chief Patient Officer, MD Healthcare and Co-Founder, Patient Information Forum, United Kingdom
Prof. Dr. Alfio Ferlito, Coordinator of the International Head and Neck Scientific Group, Padua, Italy
Prof. Dr. Nandu Goswami, Physiology, Medical University of Graz, Austria
Dr Howard Greenberg, Thomas Jefferson University, United States
Prof. Dr. Mihajlo Jakovljevic, Health Economics, Institute of Comparative Economic Studies, Hosei University, Tama Campus, Tokyo, Japan
Dr Faustino Ram Perez-Lopez, Obstetrics and Gynecology, University of Zaragoza Hospital Clínico, Zaragoza, Spain
Prof. Dr. Leopoldo Spadea, Department of Sensory Organs, Eye Clinic, Eye Clinic, Policlinico Umberto 1, Sapienza University of Rome, Italy
Professor Allan Spigelman, Surgery, University of New South Wales, Sydney, Australia
Professor Guglielmo Trovato, Medicine, University of Catania, Italy
Professor Scott Waldman, Department of Pharmacology, Physiology, and Cancer Biology, Thomas Jefferson University, Philadelphia, PA, USA
Dr Qintai Yang, Department of Otolaryngology-Head and Neck Surgery, Third Affiliated Hospital of Sun Yat-sen University, China Mainland (PRC)
Abstracting and indexing
Therapeutics and Clinical Risk Management is indexed/tracked/covered by the following services:
Current Contents®/Clinical Medicine
Directory of Open Access Journals (DOAJ)
EMBASE (Elsevier)
ICAAP
Index Copernicus
Journal Citation Reports/Science Edition
Pubmed (NLM)
PubMed Central Selective Deposit Medicine & Health (NLM)
Science Citation Index Expanded (Clarivate Analytics)
Scopus (Elsevier)
Open access
Therapeutics and Clinical Risk Management is an open access journal and only publishes open access articles. Publishing open access means that your article will be free to access online immediately on publication, increasing the visibility, readership, and impact of your research.
Why choose open access?
- Increase the discoverability and readership of your article
- Make an impact and reach new readers, not just those with easy access to a research library
- Freely share your work with anyone, anywhere
- Comply with funding mandates and meet the requirements of your institution, employer or funder
- Rigorous peer review for every open access article
Article Publishing Charges (APC)
To publish open access in this journal you may be asked to pay an Article Publishing Charge (APC). You may be able to publish your article at no cost to yourself or with a reduced APC if your institution or research funder has an open access agreement or membership with Taylor & Francis. Discounts and waivers may also be available for researchers in selected countries when publishing in open access journals.
Use our APC finder to calculate your article publishing charge
News, offers and calls for papers
Calls for papers
- Lymphoproliferation at the crossroad between haematology and immunology: molecular and clinical implications
- Unlocking the Secrets of the Nervous System: Unveiling the Biomarkers of Neurological Diseases
- Machine Learning in the Realm of Therapeutics and Clinical Risk Management
- Older and newer players in the therapeutics of Cardio-Kidney-Metabolic syndrome
Continuous
Ready to submit?
Start a new submission or continue a submission in progress
Go to submission site (link opens in a new window) Instructions for authors